Cogent Biosciences COGT
NASDAQ COGT
$31.59 -0.43 (-1.34%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cogent Biosciences (COGT) Cash from Financing Activities (2017 - 2026)

Updated

Cogent Biosciences (COGT) reported Cash from Financing Activities of $2.96 million for Q2 2026, down 93.7% from $47.23 million a year earlier and down 94.4% from the prior quarter.

Analysis

Cogent Biosciences (COGT) Cash from Financing Activities (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Cogent Biosciences' Cash from Financing Activities came in at $861.53 million; for FY2025, it came in at $878.23 million, up 309.5% from FY2024.

  • Cash from Financing Activities has a five-year compound annual growth rate of 30.5% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $214.45 million in FY2024 (+31.1%), $163.54 million in FY2023 (unchanged), $163.56 million in FY2022 (+330.7%) and $37.98 million in FY2021 (-83.6%).
  • The Q2 2026 figure ranks as the lowest quarterly Cash from Financing Activities since Q4 2024.
  • Year over year, Cash from Financing Activities gained in 1 of the last four quarters, with an average decline of 27.3%.
  • The high point for year-over-year Cash from Financing Activities in five years was Q1 2023 (growth of 222.5%); the low point was Q3 2021 (a decline of 99.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $52.54 million (Q1 2026), $588.67 million (Q4 2025) and $217.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Cogent Biosciences 5.49 Bn 5.49 Bn - 2.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.96 Mn
Mar 31, 2026 52.54 Mn
Dec 31, 2025 588.67 Mn
Sep 30, 2025 217.37 Mn
Jun 30, 2025 47.23 Mn
Mar 31, 2025 24.97 Mn
Dec 31, 2024 26,000.00
Sep 30, 2024 624,000.00
Jun 30, 2024 -256,000.00
Mar 31, 2024 214.06 Mn
Sep 30, 2023 1.00 Mn
Jun 30, 2023 162.09 Mn
Mar 31, 2023 445,000.00
Dec 31, 2022 315,000.00
Sep 30, 2022 990,000.00
Jun 30, 2022 162.12 Mn
Mar 31, 2022 138,000.00
Dec 31, 2021 38.01 Mn
Sep 30, 2021 55,000.00
Mar 31, 2021 -85,000.00
API Access

Cogent Biosciences Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=COGT&period=max&api_key=YOUR_API_KEY